Live Biotherapeutics - Microbiome Times Magazine

MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study

June 14, 2018 Microbiome Times

4D pharma plc announced that the Company has received clearance from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority (HPRA) to commence the Phase II study of Blautix, the […]

4D pharma plc enters into clinical collaboration agreement with MSD

June 13, 2018 Microbiome Times

4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of Live Biotherapeutic Products, today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) […]